Definiens Expands Management Team to Develop the Clinical Market
October 28, 2013
Today Definiens, the global leader in image analysis for digital pathology and diagnostics, announced the next step in its strategic roadmap for driving the clinical market for image analysis. Augmenting the earlier hiring of Ralf Huss as Chief Medical Officer, Definiens has added key business team members, Pablo Jordan and Rebecca Berghorn. “All experts point [...]
October 28, 2013
FRANKLIN LAKES, NJ – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, together with Direct Relief and the National Association of Community Health Centers (NACHC), today launched BD Helping Build Healthy CommunitiesSM, a four-year initiative that will expand access and improve care for underserved and vulnerable populations in the U.S. The [...]
Harvard Bioscience Appoints Yong Sun as VP Strategic Marketing and Business Development
October 28, 2013
HOLLISTON, Mass.-- Harvard Bioscience, Inc. (Nasdaq:HBIO), a global developer, manufacturer, and marketer of a broad range of tools to advance life science research and regenerative medicine, has hired Yong Sun, a veteran global marketing and sales leader in the life sciences and medical device industries, as Harvard Bioscience's Vice President Strategic Marketing and Business Development, [...]
Integrity Applications to Present at the AMIZINO Fall 2013 Small Cap/Micro Cap Investment Conference
October 28, 2013
ASHKELON, Israel -- Integrity Applications, Inc. (IGAP), developer of the GlucoTrack®model DF-F non-invasive blood glucose measurement device, announced that Avner Gal, the Company’s Chief Executive Officer, will present at the AMIZINO Fall 2013 Small Cap/Micro Cap Investment Conference at 9:00 a.m. PT on Tuesday, October 29, 2013. The conference will be held at the Sheraton [...]
October 28, 2013
SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN) today announced it has signed a definitive agreement to acquire Santa Clara-based NextBio, a leader in clinical and genomic informatics. NextBio's powerful big-data platforms aggregate and analyze large quantities of phenotypic and genomic data for research and clinical applications. With the addition of NextBio's platform upon completion of the [...]
ChIP Assay Plate for High Throughput Epigenomics
October 28, 2013
Porvair Sciences has announced that it will officially launch Chromatrap®96 HT – an innovative 96-well chromatin immunoprecipitation (ChIP) assay plate at Epigenomics of Common Diseases (Wellcome Trust, Cambridge, UK) from 7th-10th November 2013. The Chromatrap®96 HT is a new high throughput ChIP microplate based on the novel spin-column ChIP technology. It is essentially 96 separate [...]
New Managing Director Appointed at Smiths Detection Middle East
October 28, 2013
Dubai – Ed Christie has been appointed the new Managing Director of Smiths Detection Middle East, succeeding Vatheeri Chandrahood. Ed Christie brings with him an outstanding track record managing and delivering large scale civilian and military aviation projects since 2010 at Cavotec Middle East where he was Middle East Aviation Divisional Manager. Previously, he was [...]
EV Group Ships Lithography System to Micronit for Lab-On-a-Chip and Optical MEMS Device Production
October 28, 2013
MICROTAS, Freiburg, Germany - EV Group (EVG), a leading supplier of wafer bonding and lithography equipment for the MEMS, nanotechnology and semiconductor markets, today announced that it has delivered an EVG®6200 semi-automated mask alignment system to Micronit, a manufacturer of lab-on-a-chip products used in life sciences applications, such as molecular diagnostics and point-of-care, as well [...]
Optosecurity and Smiths Detection have signed a Memorandum of Understanding
October 28, 2013
Quebec - Optosecurity and Smiths Detection have signed a Memorandum of Understanding (MOU) towards developing and distributing an advanced Checkpoint Enterprise Software Solution that improves the overall performance and further cuts operational costs of security checkpoints. The MOU allows Smiths Detection and Optosecurity to begin further negotiations aimed at reaching a formal agreement. This is [...]
October 28, 2013
Gilbertsville, PA -- Rockland Immunochemicals Inc. today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Cancer Institute, National Institutes of Health (NCI/NIH) to develop nanoprobes for in vivo imaging of cancer cells and tumors that express one of the three important cancer therapeutic targets: EGFR, Her2 [...]
